<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-92582</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Systemic Diseases and the Pleura</dc:title>
<dc:description xml:lang="en">Pleural involvement in systemic diseases is usually a sign of lesions occurring at other levels. Despite thelow incidence (around 1%) of pleural effusions caused by systemic diseases, more often connective tissuediseases, such as rheumatoid arthritis or systemic lupus erythematosus, may present with this. Similarly,vasculitis, such as Wegener&#146;s granulomatosis, Churg-Strauss syndrome, or less prevalent diseases, suchas adult onset Still&#146;s disease, or human adjuvant disease, can also have pleural involvement. Althoughtheir incidence is low, it is important to take them into account when making a differential diagnosis ofa pleural effusion. In this article, the systemic diseases that include pleural involvement are reviewed, aswell as the characteristics of the effusions and their outcome(AU)</dc:description>
<dc:creator>Valdés, Luis</dc:creator>
<dc:creator>Ferreiro, Lucía</dc:creator>
<dc:creator>Álvarez-Dobaño, José Manuel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La afectación pleural en las enfermedades sistémicas suele ser un reflejo de las lesiones que se producena otros niveles. A pesar de la baja incidencia de derrame pleural causado por enfermedades sistémicas(alrededor del 1%), las conectivopatías más frecuentes como la artritis reumatoide o el lupus eritematososistémico pueden presentarlo. De la misma forma, vasculitis como la granulomatosis de Wegener, elsíndrome de Churg-Strauss, enfermedades menos prevalentes como la enfermedad de Still de inicioen el adulto, o la enfermedad adyuvante humana, también pueden tener la pleura afectada. Aunquesu incidencia es baja, es importante tenerlas en cuenta a la hora de realizar el diagnóstico diferencialdel derrame pleural. En este artículo se revisan las enfermedades sistémicas que cursan con afectaciónpleural, así como las características del derrame y la evolución del mismo(AU)</dc:description>
<dc:source>Arch Bronconeumol;47(7): 361-370, jul. 2011. tab</dc:source>
<dc:identifier>ibc-92582</dc:identifier>
<dc:title xml:lang="es">Enfermedades sistémicas y pleura</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d11425^s22011</dc:subject>
<dc:subject>^d11425^s22016</dc:subject>
<dc:subject>^d11425^s22027</dc:subject>
<dc:subject>^d9137^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8356^s22012</dc:subject>
<dc:subject>^d29808^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24314^s22012</dc:subject>
<dc:subject>^d3902^s22012</dc:subject>
<dc:subject>^d15059^s22012</dc:subject>
<dc:subject>^d13552^s22012</dc:subject>
<dc:subject>^d28302^s22012</dc:subject>
<dc:subject>^d12886^s22012</dc:subject>
<dc:subject>^d12976^s22012</dc:subject>
<dc:subject>^d1178^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201107</dc:date>
</metadata>
</record>
</ibecs-document>
